|
US8992984B1
(en)
|
2009-10-21 |
2015-03-31 |
Stc.Unm |
Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2821992A1
(en)
|
2010-10-01 |
2012-04-05 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
EP2701686A4
(en)
|
2011-04-28 |
2014-11-05 |
Stc Unm |
LIPID BINCHES SUPPORTED ON POROUS NANOPARTICLES (PROTOCELLS) FOR TARGETED ADMINISTRATION, AND METHODS OF USE THEREOF
|
|
US9532949B2
(en)
|
2011-07-19 |
2017-01-03 |
Stc.Unm |
Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
HRP20220250T1
(hr)
|
2011-10-03 |
2022-04-29 |
Modernatx, Inc. |
Modificirani nukleozidi, nukleotidi i nukleinske kiseline, te njihove uporabe
|
|
SI2791160T1
(sl)
|
2011-12-16 |
2022-07-29 |
Modernatx, Inc. |
Sestave modificirane MRNA
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
AU2013243952A1
(en)
|
2012-04-02 |
2014-10-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9273305B1
(en)
|
2012-04-25 |
2016-03-01 |
Sandia Corporation |
Cell-based composite materials with programmed structures and functions
|
|
PL2919903T3
(pl)
|
2012-11-14 |
2020-12-14 |
W.R. Grace & Co. - Conn. |
Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny
|
|
ES2627195T3
(es)
|
2012-11-16 |
2017-07-27 |
University College Cardiff Consultants Limited |
Mezcla de RP/SP gemcitabina-[fenil-(bencloxi-l-alaninil)]-fosfato
|
|
SMT202200337T1
(it)
|
2012-11-26 |
2022-09-14 |
Modernatx Inc |
Rna modificato al livello del terminale
|
|
EP2964201B1
(en)
|
2013-03-05 |
2024-02-14 |
The Regents of the University of California |
Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2014201276A1
(en)
*
|
2013-06-12 |
2014-12-18 |
The Methodist Hospital |
Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents
|
|
WO2015013352A2
(en)
*
|
2013-07-25 |
2015-01-29 |
Patel Hasmukh B |
Nucleoside phosphoramidates and phosphoramidites
|
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
US20160287717A1
(en)
*
|
2013-09-18 |
2016-10-06 |
Stc.Unm |
Core and Surface Modification of Mesoporous Silica Nanoparticles to Achieve Cell Specific Targeting In Vivo.
|
|
WO2015042279A1
(en)
*
|
2013-09-18 |
2015-03-26 |
Stc. Unm |
Torroidal mesoporous silica nanoparticles (tmsnps) and related protocells
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015066717A1
(en)
|
2013-11-04 |
2015-05-07 |
BioPharmX, Inc. |
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
|
|
CN106133136A
(zh)
*
|
2014-01-17 |
2016-11-16 |
松尾洋孝 |
痛风发病关联分子、尿酸关联疾病素质与炎症关联疾病素质的评价方法及评价试剂盒、检查体及药物
|
|
WO2016011226A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
EP3173074A4
(en)
|
2014-07-22 |
2018-03-07 |
Lemonex Inc. |
Composition for delivering bioactive material or protein, and use thereof
|
|
WO2016014846A1
(en)
|
2014-07-23 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
WO2016054225A1
(en)
*
|
2014-09-30 |
2016-04-07 |
Stc.Unm |
Plasmid delivery in the treatment of cancer and other disease states
|
|
CA2966850C
(en)
|
2014-11-05 |
2024-03-26 |
Selecta Biosciences, Inc. |
Methods and compositions related to the use of low hlb surfactants in the production of synthetic nanocarriers comprising a rapalog
|
|
WO2016145031A1
(en)
*
|
2015-03-09 |
2016-09-15 |
Stc.Unm |
Cd 47 containing porous nanoparticle supported lipid bilayers (protocells)
|
|
US11643445B2
(en)
*
|
2015-04-24 |
2023-05-09 |
Colgate-Palmolive Company |
Porous protein particles as carriers for actives
|
|
JP6894423B2
(ja)
*
|
2015-07-09 |
2021-06-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
融合性リポソーム被覆多孔質ケイ素ナノ粒子
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
US10624949B1
(en)
|
2015-07-27 |
2020-04-21 |
National Technology & Engineering Solutions Of Sandia, Llc |
Methods for treating diseases related to the wnt pathway
|
|
CA2998810A1
(en)
|
2015-09-17 |
2017-03-23 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
KR20180063885A
(ko)
*
|
2015-09-24 |
2018-06-12 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
전이 감소를 위한 방법 및 조성물
|
|
CN105174211B
(zh)
*
|
2015-10-12 |
2017-02-01 |
海南大学 |
一种具有表面增强拉曼活性银基复合纳米材料的制备方法及其所得产品和应用
|
|
EP4349405A3
(en)
|
2015-10-22 |
2024-06-19 |
ModernaTX, Inc. |
Respiratory virus vaccines
|
|
EP3364982A4
(en)
|
2015-10-22 |
2019-04-17 |
ModernaTX, Inc. |
VACCINES AGAINST SEXUALLY TRANSMITTED DISEASES
|
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
|
EA201891001A1
(ru)
|
2015-10-22 |
2018-11-30 |
МОДЕРНАТиЭкс, ИНК. |
Вакцины на основе нуклеиновых кислот против вируса ветряной оспы (vzv)
|
|
JP6667896B2
(ja)
*
|
2015-11-06 |
2020-03-18 |
国立研究開発法人産業技術総合研究所 |
リボ核酸固定化担体及びそれを用いたリボ核酸の分離回収方法
|
|
ES2924407T3
(es)
|
2015-12-10 |
2022-10-06 |
Modernatx Inc |
Composiciones y procedimientos para el suministro de agentes terapéuticos
|
|
SMT202200252T1
(it)
|
2015-12-22 |
2022-07-21 |
Modernatx Inc |
Composti e composizioni per il rilascio intracellulare di agenti
|
|
PL3394093T3
(pl)
|
2015-12-23 |
2022-05-16 |
Modernatx, Inc. |
Metody stosowania polinukleotydów kodujących ligand ox40
|
|
US11672866B2
(en)
|
2016-01-08 |
2023-06-13 |
Paul N. DURFEE |
Osteotropic nanoparticles for prevention or treatment of bone metastases
|
|
EP4218739A3
(en)
*
|
2016-01-08 |
2023-08-09 |
The Regents of The University of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
|
EP3400023A1
(en)
|
2016-01-10 |
2018-11-14 |
ModernaTX, Inc. |
Therapeutic mrnas encoding anti ctla-4 antibodies
|
|
CN114949250A
(zh)
*
|
2016-04-14 |
2022-08-30 |
斯宾纳克生物科学公司 |
用于递送治疗剂的组合物、药物组合物、制备方法以及用途
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
US11555177B2
(en)
*
|
2016-07-13 |
2023-01-17 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
EP3269444A1
(en)
*
|
2016-07-14 |
2018-01-17 |
Base4 Innovation Ltd |
Method of identifying droplets in a stack and an associated sequencer
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
EP3538146A4
(en)
|
2016-11-11 |
2020-07-15 |
ModernaTX, Inc. |
INFLUENZA VACCINE
|
|
MA50335A
(fr)
|
2016-12-08 |
2020-08-19 |
Modernatx Inc |
Vaccins à acide nucléique contre des virus respiratoires
|
|
LU100023B1
(en)
*
|
2017-01-20 |
2018-07-30 |
Luxembourg Inst Science & Tech List |
Nanocapsules and method for manufacturing thereof
|
|
CN106822916B
(zh)
*
|
2017-01-25 |
2020-02-28 |
浙江大学 |
一种pH敏感的纳米化Bcl-2选择性抑制剂的制备方法及产物和应用
|
|
SG11201906744VA
(en)
*
|
2017-01-27 |
2019-08-27 |
Methodist Hospital |
Core/shell structure platform for immunotherapy
|
|
CN119564881A
(zh)
|
2017-02-06 |
2025-03-07 |
雷莫内克斯生物制药有限公司 |
生理活性物质载体
|
|
US11344629B2
(en)
|
2017-03-01 |
2022-05-31 |
Charles Jeffrey Brinker |
Active targeting of cells by monosized protocells
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
EP3595713A4
(en)
|
2017-03-15 |
2021-01-13 |
ModernaTX, Inc. |
Respiratory syncytial virus vaccine
|
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
AU2018234828A1
(en)
|
2017-03-15 |
2019-09-19 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
US11752206B2
(en)
|
2017-03-15 |
2023-09-12 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
EP3596041B1
(en)
|
2017-03-15 |
2022-11-02 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
AU2018234814B2
(en)
|
2017-03-15 |
2022-06-30 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
WO2018232357A1
(en)
|
2017-06-15 |
2018-12-20 |
Modernatx, Inc. |
Rna formulations
|
|
US11007516B1
(en)
|
2017-06-19 |
2021-05-18 |
National Technology & Engineering Solutions Of Sandia, Llc |
Tunable metal-organic framework compositions and methods thereof
|
|
CN116898870A
(zh)
*
|
2017-07-28 |
2023-10-20 |
雷莫内克斯生物制药有限公司 |
用于预防或治疗肝癌的药物组合物
|
|
US11744801B2
(en)
|
2017-08-31 |
2023-09-05 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
KR102152348B1
(ko)
|
2017-09-05 |
2020-09-08 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
WO2019050283A1
(ko)
*
|
2017-09-05 |
2019-03-14 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
EP3681514A4
(en)
|
2017-09-14 |
2021-07-14 |
ModernaTX, Inc. |
RNA VACZINE AGAINST ZIKA VIRUS
|
|
US10933027B1
(en)
*
|
2017-09-25 |
2021-03-02 |
National Technology & Engineering Solutions Of Sandia, Llc |
Expanded pore particles and delivery methods thereof
|
|
CN107952076A
(zh)
*
|
2017-11-07 |
2018-04-24 |
徐州医科大学 |
一种多囊脂质体/多孔碳纳米复合物、制备方法及应用
|
|
EP3710065B1
(en)
*
|
2017-11-13 |
2024-08-21 |
Politecnico Di Torino |
Biomimetic non-immunogenic nanoassembly for the antitumor therapy
|
|
US11661599B1
(en)
|
2017-12-14 |
2023-05-30 |
National Technology & Engineering Solutions Of Sandia, Llc |
CRISPR-Cas based system for targeting single-stranded sequences
|
|
US12383499B2
(en)
|
2018-01-01 |
2025-08-12 |
The Regents Of The University Of California |
Scale up synthesis of silicasome nanocarriers
|
|
MA54676A
(fr)
|
2018-01-29 |
2021-11-17 |
Modernatx Inc |
Vaccins à base d'arn contre le vrs
|
|
KR102017110B1
(ko)
|
2018-03-08 |
2019-09-02 |
한국화학연구원 |
구역화된 간소엽 모사체 및 이를 이용한 구역별 간독성 평가방법
|
|
CA3097411A1
(en)
*
|
2018-04-18 |
2019-10-24 |
Oisin Biotechnologies, Inc. |
Fusogenic lipid nanoparticles and methods for the target cell-specific production of a therapeutic protein
|
|
AU2019255725A1
(en)
*
|
2018-04-18 |
2020-12-10 |
Ligandal, Inc. |
Methods and compositions for genome editing
|
|
CA3097512A1
(en)
|
2018-05-18 |
2019-11-21 |
F. Hoffmann-La Roche Ag |
Targeted intracellular delivery of large nucleic acids
|
|
US11045554B1
(en)
|
2018-06-22 |
2021-06-29 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid-coated particles for treating viral infections
|
|
AU2019317939A1
(en)
*
|
2018-08-06 |
2021-04-01 |
Lemonex Inc. |
Immunoreactant carrier
|
|
WO2020037530A1
(en)
*
|
2018-08-22 |
2020-02-27 |
Waterstone Pharmaceuticals (Wuhan) Co., Ltd. |
Crystalline form of compound and uses thereof in medicine
|
|
JP7640452B2
(ja)
|
2018-09-19 |
2025-03-05 |
モデルナティエックス インコーポレイテッド |
高純度ｐｅｇ脂質及びそれらの使用
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020061284A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Peg lipids and uses thereof
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
WO2020068798A1
(en)
|
2018-09-24 |
2020-04-02 |
Guo Jimin |
Living mammalian cells modified with functional modular nanoparticles
|
|
KR20200051916A
(ko)
*
|
2018-11-05 |
2020-05-14 |
주식회사 메디포럼제약 |
고세렐린을 포함하는 실리카 하이드로겔 조성물
|
|
US20220049216A1
(en)
*
|
2018-12-24 |
2022-02-17 |
Korea University Research And Business Foundation |
Manufacture of structure capable of forming three-dimensional neuronal spheroid and generating neurite through various surface processes
|
|
IT201900001009A1
(it)
|
2019-01-23 |
2020-07-23 |
Torino Politecnico |
Vettore nanoporoso biomimetico comprendente un inibitore diretto verso la forma nativa della proteina IDH2
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
WO2020171680A1
(ko)
*
|
2019-02-22 |
2020-08-27 |
주식회사 레모넥스 |
면역활성 또는 암의 예방 또는 치료용 의약 조성물
|
|
WO2020176716A1
(en)
|
2019-02-28 |
2020-09-03 |
Brinker C Jeffrey |
Modular metal–organic polyhedra superassembly compositions
|
|
US12070495B2
(en)
|
2019-03-15 |
2024-08-27 |
Modernatx, Inc. |
HIV RNA vaccines
|
|
GB201904337D0
(en)
*
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
GB201904334D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
Carrier system for preparing herbaceous extracts
|
|
GB201904336D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
EP3714879A1
(en)
|
2019-03-28 |
2020-09-30 |
Sisaf Ltd |
Structured encapsulated silicon-containing particles
|
|
WO2020200472A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Biontech Rna Pharmaceuticals Gmbh |
Preparation and storage of liposomal rna formulations suitable for therapy
|
|
US12377118B2
(en)
*
|
2019-08-09 |
2025-08-05 |
Case Western Reserve University |
Nanoparticle constructs for systemic co-delivery of anti-tumor agents
|
|
US11066355B2
(en)
|
2019-09-19 |
2021-07-20 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
AR121356A1
(es)
|
2020-02-18 |
2022-05-11 |
Gilead Sciences Inc |
Compuestos antivirales
|
|
TWI883391B
(zh)
|
2020-02-18 |
2025-05-11 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI874791B
(zh)
|
2020-02-18 |
2025-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
BR112022018070A2
(pt)
|
2020-03-11 |
2022-10-25 |
Selecta Biosciences Inc |
Métodos e composições relacionados a nanoveículos sintéticos
|
|
US20230133587A1
(en)
*
|
2020-03-26 |
2023-05-04 |
Chinese Institute For Brain Research, Beijing |
Amino Acid Mediated Gene Delivery and Its Uses
|
|
EP4125816A4
(en)
*
|
2020-04-01 |
2024-01-10 |
University of Cincinnati |
MATERIALS AND METHODS FOR IMMUNOSUPRESSIVE TUMOR MICRO-TARGETED CANCER THERAPY
|
|
US11433121B1
(en)
*
|
2020-04-03 |
2022-09-06 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid composition for the delivery of therapeutic cargos
|
|
CN113713115B
(zh)
*
|
2020-05-22 |
2023-11-24 |
青岛科技大学 |
一种采用碳多孔材料构建抗癌载药系统的方法
|
|
GB2600704A
(en)
*
|
2020-11-04 |
2022-05-11 |
Sumitomo Chemical Co |
Nanoparticle
|
|
WO2022115075A1
(en)
*
|
2020-11-30 |
2022-06-02 |
Ege Üni̇versi̇tesi̇ |
Targeted nanoparticles carrying dual drugs in the treatment of melanoma
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
CN112870387B
(zh)
*
|
2021-02-26 |
2023-08-29 |
中山大学孙逸仙纪念医院 |
一种磁性纳米药物载体及其制备方法和应用
|
|
WO2022192674A1
(en)
*
|
2021-03-11 |
2022-09-15 |
The Trustees Of The University Of Pennsylvania |
Targeted therapeutic lipid nanoparticles and methods of use
|
|
CN113149023B
(zh)
*
|
2021-03-11 |
2023-05-02 |
昆明理工大学 |
一种介孔二氧化硅纳米颗粒经皮递送低共熔体系制备方法
|
|
EP4323362B1
(en)
|
2021-04-16 |
2025-05-07 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
|
CN113082226B
(zh)
*
|
2021-04-27 |
2023-12-15 |
山东中医药大学 |
一种载药纳米笼的制备方法与其靶向循环肿瘤细胞释放雷公藤甲素的应用
|
|
CA3228162A1
(en)
|
2021-08-18 |
2023-02-23 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
CN113735350B
(zh)
*
|
2021-09-23 |
2023-01-24 |
深圳市水务规划设计院股份有限公司 |
一种黑臭水体处理工艺及其实验装置
|
|
JP7717252B2
(ja)
*
|
2021-10-13 |
2025-08-01 |
タンペレ・ユニバーシティー・ファウンデーション・エスアール |
細胞培養システム
|
|
CN114129718B
(zh)
*
|
2021-10-19 |
2024-05-03 |
华东师范大学 |
一种用于体内自组装car-t的纳米递送系统及其制备方法和应用
|
|
WO2023161350A1
(en)
|
2022-02-24 |
2023-08-31 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
US12145890B2
(en)
|
2022-12-16 |
2024-11-19 |
Raytheon Company |
Coated (core-shell) nanoparticles for nanocomposite optical ceramics
|
|
CN116327975A
(zh)
*
|
2022-12-20 |
2023-06-27 |
中国科学院基础医学与肿瘤研究所(筹) |
一种醋酸棉酚硅脂体及其制备方法和用途
|
|
CN116327985B
(zh)
*
|
2023-02-21 |
2024-09-27 |
武汉工程大学 |
一种具有靶向超声造影成像功能的空心囊泡载药递送系统及其制备方法与应用
|
|
WO2024237645A1
(ko)
*
|
2023-05-15 |
2024-11-21 |
주식회사 엠피오스 |
소수성 약물의 서방출용 실리카 기반 나노입자, 이의 제조방법 및 이를 포함하는 경피 약물투여시스템
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|